Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
11.16
-0.95 (-7.84%)
At close: Nov 10, 2026, 4:00 PM EST
11.17
+0.01 (0.09%)
After-hours: Nov 10, 2026, 6:18 PM EST

Intellia Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
156.1155.46189.18226.75523.51123.41
Short-Term Investments
318.01294.42412.33685.48669.12625.28
Cash & Short-Term Investments
474.11449.88601.52912.221,193748.69
Cash Growth
-7.23%-25.21%-34.06%-23.51%59.29%25.33%
Receivables
7.59.478.5236.463.772.03
Prepaid Expenses
24.7468.3629.8347.5520.4118.58
Other Current Assets
---2.1--
Total Current Assets
506.35527.71639.86998.331,217769.3
Property, Plant & Equipment
226.41123.63246.67148.14161100.11
Long-Term Investments
152.19177.71287.09136.39126.59420.29
Other Long-Term Assets
17.6113.0817.3918.1215.734.76
Total Assets
902.56842.131,1911,3011,5201,294

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
12.5520.2514.597.455.159.65
Accrued Expenses
46.7749.8655.3660.1360.8843.31
Current Portion of Leases
20.9826.4820.2518.616.699.11
Current Unearned Revenue
-7.2920.6622.1443.8463.76
Other Current Liabilities
---6.89--
Total Current Liabilities
80.31103.88110.85115.21126.55125.83
Long-Term Leases
135.4366.85189.9596.75114.0264.91
Long-Term Unearned Revenue
--18.2638.8519.9363.48
Other Long-Term Liabilities
----24.03-
Total Liabilities
289.47170.73319.06250.81284.53254.22

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010.01
Additional Paid-In Capital
3,5363,2603,0492,7112,4201,746
Retained Earnings
-2,920-2,590-2,177-1,658-1,177-703
Comprehensive Income & Other
-2.561.030.61-2.26-7.46-2.63
Total Common Equity
613.09671.39871.961,0501,2361,040
Shareholders' Equity
613.09671.39871.961,0501,2361,040
Total Liabilities & Equity
902.56842.131,1911,3011,5201,294

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
230.1493.33210.2115.35130.774.02
Net Cash (Debt)
384.66511.81651.53896.741,1311,012
Net Cash Growth
-32.74%-21.45%-27.34%-20.73%11.78%81.34%
Net Cash Per Share
3.034.726.5910.1014.7014.28
Filing Date Shares Outstanding
140.36118.13103.5296.1188.0274.67
Total Common Shares Outstanding
140.25116.32102.039387.174.49
Working Capital
426.04423.83529.01883.121,090643.47
Book Value Per Share
4.375.778.5511.2914.1913.97
Tangible Book Value
613.09671.39871.961,0501,2361,040
Tangible Book Value Per Share
4.375.778.5511.2914.1913.97
Machinery
-71.1671.9767.5956.3343.34
Leasehold Improvements
-3.23.23.133.072.19
SEC Filings: 10-K · 10-Q